Beating Cardiac Bodies

Beating Cardiac Bodies

 A Complete Workflow

Stem cell derived cardiomyocytes gain more and more attention in the field of cardiovascular research, disease modeling and drug development.

The CERO 3D Incubator & Bioreactor platform streamlines the process, enabling stem cell expansion into uniform aggregates followed by direct induction into a high yield of beating cardiac bodies. Compared to traditional orbital shakers, CERO 3D offers superior cell quality, homogeneity, integrity, and yield in both pluripotent stem cell expansion and cardiac differentiation. 


CERO 3D Incubator & Bioreactor versus Orbital Shaker – Differentiation of Murine Embryonic Stem Cell-Derived Cardiomyocytes at Days 3, 8, and 13 Post-Induction
  • Homogeneous 3D aggregates in suspension
  • Expansion and differentiation in the same CEROtube
  • Easy to handle & standardize
  • Highest yield, no substrate required
  • Greater relevance for drug testing and disease modeling



Purified and homogeneous cardiac bodies generated in CERO 3D Incubator & Bioreactor are a perfect tool for disease modeling and drug discovery. The pure cardiomyocytes can also be used in 2D downstream monolayer applications.



​

Cardiac Tissiue Bodies - Request a Free Demo Today 


DownloaD cardiac tissue report 

Scale up your cardiac tissue research with CERO 3D. Achieve efficient, high-yield pluripotent stem cell expansion and differentiation into cardiac, neural, and hepatic lineages with a streamlined, cost-effective workflow. The CERO 3D Incubator & Bioreactor enables automated, microcarrier-free 3D culture, ensuring homogeneous cell aggregates and robust scalability.


Optimize your cardiac bodies workflows with CERO 3D. Request a free demo today!​


​​​​​​​​​​Request a Free Demo​​​​